← Back to headlines
Eliquis to be Available on Mark Cuban Cost Plus Drug Platform
The anticoagulant drug Eliquis, a product of Bristol-Myers Squibb and Pfizer, is slated to become available through Mark Cuban's Cost Plus Drug Company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
